1980
DOI: 10.1002/bdd.2510010307
|View full text |Cite
|
Sign up to set email alerts
|

The effect of displacement from protein binding on serum and tissue fluid levels of cephazolin

Abstract: Displacement of cephazolin, a highly protein-bound beta-lactam antibiotic, by sulpha-phenazole was studied in vitro and in vivo. In vitro, the sulphonamide was effective in displacing the antibiotic from its binding sites at the concentration 100--1000 mumol 1(-1). In vivo, both the serum and the tissue fluid concentration of free cephazolin increased significantly in rats concomitantly treated with sulphaphenazole.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1980
1980
2006
2006

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…This could be due to displacement of the binding of omeprazole by the enzyme inhibitors. Displacement of plasma (serum) protein binding of tolbutamide [34] and cefazolin [35] by sulfaphenazole, and of oxprenolol and propranolol by SKF 525-A [36] were also reported. The time intervals between pretreatment of enzyme inhibitors and omeprazole dosing are short (0, 1, 1 and 2 h for sulfaphenazole, SKF 525-A, quinine and troleandomycin, respectively), therefore, it could be expected that the inhibitors were present in the plasma.…”
Section: Measurement Of Plasma Protein Binding Of Omeprazolementioning
confidence: 99%
“…This could be due to displacement of the binding of omeprazole by the enzyme inhibitors. Displacement of plasma (serum) protein binding of tolbutamide [34] and cefazolin [35] by sulfaphenazole, and of oxprenolol and propranolol by SKF 525-A [36] were also reported. The time intervals between pretreatment of enzyme inhibitors and omeprazole dosing are short (0, 1, 1 and 2 h for sulfaphenazole, SKF 525-A, quinine and troleandomycin, respectively), therefore, it could be expected that the inhibitors were present in the plasma.…”
Section: Measurement Of Plasma Protein Binding Of Omeprazolementioning
confidence: 99%